T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response

DOI: 10.1080/2162402X.2018.1494112

Keywords: TCR, immunosequencing, cetuximab, EGFR, cytotoxic T cells, head and neck cancer, immunotherapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text